First line asciminib in chronic myeloid leukemia: a quest for the “Holy Grail” of tolerability.

Authors

Institutions

Publication Details

Journal
Haematologica
Published
2026-09-10
DOI
https://doi.org/10.3324/haematol.2026.301753
Primary Topic
Chronic Myeloid Leukemia Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

First line asciminib in chronic myeloid leukemia: a quest for the “Holy Grail” of tolerability.

Delphine Réa
Haematologica
Chronic Myeloid Leukemia Treatments
article

First line asciminib in chronic myeloid leukemia: a quest for the “Holy Grail” of tolerability.

Delphine Réa
article en

Abstract

No abstract available for this paper.
Haematologica
Saint Louis University Hospital (US)
Zero hunger
Openalex Percentile: Top 10%
Chronic Myeloid Leukemia Treatments
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.